About the Authors
- Oscar Holmström
-
Affiliations Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
- Nina Linder
-
Affiliations Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
- Mikael Lundin
-
Affiliation Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland
- Hannu Moilanen
-
Affiliation Center of Microscopy and Nanotechnology, University of Oulu, Oulu, Finland
- Antti Suutala
-
Affiliation Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland
- Riku Turkki
-
Affiliation Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland
- Heikki Joensuu
-
Affiliations Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
- Jorma Isola
-
Affiliation BioMediTech, University of Tampere, Tampere, Finland
- Vinod Diwan
-
Affiliation Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
- Johan Lundin
-
* E-mail: johan.lundin@helsinki.fi
Affiliations Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden
Competing Interests
Johan Lundin is the founder and co-owner of Fimmic Oy, Helsinki, Finland. Jorma Isola is the founder and owner of Jilab Inc, Tampere, Finland. The authors confirm that these interests do not alter their adherence to the data and material sharing policies of PLOS ONE.
Author Contributions
Conceived and designed the experiments: JL OH VD. Performed the experiments: OH RT. Analyzed the data: OH JL. Contributed reagents/materials/analysis tools: HM AS ML JL VD JI. Wrote the paper: OH JL NL HJ. Commented the manuscript: OH NL ML HM AS RT HJ JI VD JL. Supervised the project: JL.